title: Deoxygenated blood minimizes adherence of sonicated albumin microbubbles during cardioplegic arrest and after blood reperfusion: experimental and clinical observations with myocardial contrast echocardiography.
abstract: Both administration of cardioplegic solution and blood reperfusion result in endothelial dysfunction. The transit rate of albumin microbubbles during myocardial contrast echocardiography may reflect endothelial injury. Accordingly, we performed myocardial contrast echocardiography in 12 dogs undergoing cardiopulmonary bypass and measured the myocardial transit rate of microbubbles injected into the aortic root during delivery of cardioplegic solutions containing arterial and venous blood and delivery of pure crystalloid cardioplegic solution. The myocardial transit rate of 99mTc-labeled red blood cells was measured and perfusates were sampled for biochemical analysis at each stage. The microbubble transit rate was markedly prolonged during delivery of crystalloid cardioplegic solution and improved significantly during infusion of blood cardioplegic solution (p < 0.001); venous compared with arterial blood in the solution resulted in a greater rate (p < 0.001). The microbubble transit rate did not correlate with pH, oxygen tension or carbon dioxide tension values, or K+ concentration. The red blood cell transit rate remained constant regardless of the cardioplegic perfusate infused. Myocardial contrast echocardiography was also performed in 12 patients undergoing coronary artery bypass who underwent sequential arterial and venous reperfusion after cardioplegic arrest. The microbubble transit rate was faster with venous than arterial blood reperfusion (p = 0.01), although this gain was diminished when arterial blood reperfusion preceded venous blood reperfusion (p = 0.05). Our results indicate that endothelial dysfunction after cardioplegic arrest may be ameliorated by reperfusion with venous rather than arterial blood.
authors.affiliation: Division of Thoracic and Cardiovascular Surgery, University of Virginia School of Medicine, Charlottesville 22908, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: Bayfield
authors.forename: J R
authors.initials: JR
authors.lastname: Lindner
authors.forename: S
authors.initials: S
authors.lastname: Kaul
authors.forename: S
authors.initials: S
authors.lastname: Ismail
authors.forename: M L
authors.initials: ML
authors.lastname: Sheil
authors.forename: N C
authors.initials: NC
authors.lastname: Goodman
authors.forename: R
authors.initials: R
authors.lastname: Zacour
authors.forename: W D
authors.initials: WD
authors.lastname: Spotnitz
mesh_terms: D000418:Albumins; D000818:Animals; D001769:Blood; D002314:Cardioplegic Solutions / Q000737:chemistry; D002315:Cardiopulmonary Bypass; D004195:Disease Models, Animal; D004285:Dogs; D004452:Echocardiography; D004730:Endothelium, Vascular / Q000473:pathology / Q000503:physiopathology; D004912:Erythrocytes / Q000502:physiology; D006324:Heart Arrest, Induced; D008297:Male; D015425:Myocardial Reperfusion; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D000418:Albumins; D002314:Cardioplegic Solutions